Integration of breaking-point transition probabilities and specific open chromatin region features for early cancer detection.
New epigenomic blood test detects multiple cancers early by reading tumour chromatin patterns, outperforming existing approaches.
Ji et al. developed a computational framework integrating breaking-point transition probabilities derived from chromatin accessibility signatures in cfDNA with open chromatin region features for multi-cancer early detection from liquid biopsy. The method achieved superior detection performance on benchmark datasets compared to existing fragment-based cfDNA approaches, providing proof-of-concept for an epigenomic liquid biopsy strategy that captures tumour-specific chromatin remodelling patterns.
What the study was
- Study design
- Computational/bioinformatics proof-of-concept study
- Population
- In silico: cancer patient cfDNA datasets used for algorithm development and benchmarking
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Cell Commun Signal
Why it surfaced
Methodologically innovative cfDNA approach using chromatin accessibility signatures; open-access Cell Commun Signal; addresses T3 core objective with high algorithmic novelty.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.